These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17636695)

  • 1. Surfactant for meconium aspiration syndrome in full term/near term infants.
    El Shahed AI; Dargaville P; Ohlsson A; Soll RF
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002054. PubMed ID: 17636695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant for meconium aspiration syndrome in term and late preterm infants.
    El Shahed AI; Dargaville PA; Ohlsson A; Soll R
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD002054. PubMed ID: 25504256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant for meconium aspiration syndrome in full term infants.
    Soll RF; Dargaville P
    Cochrane Database Syst Rev; 2000; (2):CD002054. PubMed ID: 10796463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung lavage for meconium aspiration syndrome in newborn infants.
    Hahn S; Choi HJ; Soll R; Dargaville PA
    Cochrane Database Syst Rev; 2013 Apr; (4):CD003486. PubMed ID: 23633311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC; Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Bahadue FL; Soll R
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF; Blanco F
    Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic surfactant for respiratory distress syndrome in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1997(2):CD000511. PubMed ID: 10796380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant therapy for meconium aspiration syndrome: current status.
    Dargaville PA; Mills JF
    Drugs; 2005; 65(18):2569-91. PubMed ID: 16392874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant therapy and antibiotics in neonates with meconium aspiration syndrome: a systematic review and meta-analysis.
    Natarajan CK; Sankar MJ; Jain K; Agarwal R; Paul VK
    J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S49-54. PubMed ID: 27109092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD000141. PubMed ID: 10796305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.